Phenibut
β-phenyl-GABA
Phenibut (β-phenyl-GABA) is a cognitive & mood research compound. GABA-B (and mild GABA-A) agonist with calcium-channel effects — crosses the blood-brain barrier where GABA can't, producing anxiolysis and sociability.
Phenibut quick facts
| Reported research dose | 250mg-1000mg |
| Route | Oral |
| Frequency | ≤2x weekly |
| Half-life | ~5 hrs |
| Forms | Oral |
| Evidence level | Human (Russia) |
Works, but genuinely habit-forming — tolerance and withdrawal are real. Occasional use ONLY, never daily. I'm cautious recommending it.
How Phenibut works
GABA-B (and mild GABA-A) agonist with calcium-channel effects — crosses the blood-brain barrier where GABA can't, producing anxiolysis and sociability.
Proposed benefits
Researched for focus, memory, neuroprotection, mood and stress resilience.
✅ Clinically validated
- Developed in the Soviet Union in the 1960s and still a registered medicine in Russia and several former Soviet states for anxiety and insomnia, with domestic clinical use behind it. No Western approval and no modern randomised trials.
- The clinical literature that matters most in the West is the case-report literature on dependence and withdrawal — emergency presentations with severe withdrawal are documented in peer-reviewed journals, and several countries have moved to restrict it.
📊 Correlative data
- Very heavy community use and the most consistently reported problem set of anything in this category: tolerance within days, and a withdrawal syndrome that closely resembles benzodiazepine withdrawal — insomnia, severe rebound anxiety, and in serious cases seizures.
- Occasional use is reported as reliably anxiolytic and pro-social. The gap between occasional and daily use is the entire risk profile.
🧪 Theoretical / extrapolated
- A GABA analogue with a phenyl ring that lets it cross the blood-brain barrier. It is a GABA-B receptor agonist — the same receptor baclofen and GHB act on — with additional activity at α2δ calcium channels like gabapentin.
- GABA-B agonism is why the dependence pattern looks the way it does. Receptor downregulation with sustained agonism is rapid, and the rebound when it is removed is the mechanism running in reverse. That is not a misuse phenomenon — it is what the pharmacology predicts from daily use.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Phenibut — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- This group acts directly on established CNS receptors — GABA-B (phenibut), serotonergic and histaminergic (trazodone, doxepin), beta-adrenergic (propranolol), dopaminergic (cabergoline, apomorphine). These are pharmacological drugs, not research peptides, and the predicted problems are the known ones for each receptor.
- Phenibut is the one that needs saying plainly: it is physically addictive. GABA-B agonism produces tolerance within days of regular use, and withdrawal is genuinely severe — anxiety, insomnia, tremor, and in heavy users, psychosis and seizures. It is closer to a benzodiazepine than to a nootropic in this respect, and it is sold as though it were the latter.
- Propranolol blunts the physical symptoms of adrenaline. That predicts the useful effect and also the problem — it blunts the training response and masks hypoglycaemia.
- Dopamine agonists predict nausea, orthostatic hypotension and, at the doses used in Parkinson's, impulse-control problems. Cabergoline's half-life is very long, so effects persist well past a dose.
What has actually been reported
- Phenibut dependence and withdrawal are well documented in case reports and poison-centre data.
- Trazodone: sedation, orthostatic hypotension, and rarely priapism — which is a medical emergency.
- Abrupt propranolol cessation causes rebound tachycardia and hypertension. Do not stop a beta-blocker suddenly.
- Cabergoline at high cumulative doses is associated with cardiac valve changes; at the low doses used for prolactin this has not been shown.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- For phenibut, the only reliable mitigation is frequency: occasional use does not produce dependence, regular use does. There is no dose that makes daily use safe.
- Taper anything in this group rather than stopping abruptly.
- Take the first dose of anything with orthostatic effects at home, sitting down.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- Prolactin if using cabergoline (it is usually why you are). Otherwise blood pressure and heart rate are the monitoring that matters.
Don't run this if
- You already take a sedative, a benzodiazepine, or drink regularly — the CNS depressant effects are additive and this is where respiratory depression comes from.
- You are on an antidepressant and considering trazodone — serotonergic combinations need a prescriber, not a forum.
The honest unknown
- Most of this group is well characterised for its licensed use. What is NOT characterised is the off-label use most people here are making of it, at doses and durations nobody studied.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Phenibut
Buy Phenibut at Disguised Alpha →Phenibut — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Phenibut moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Most of this class has no predicted marker movement at all, and saying so is more useful than listing markers that will not move.
What to do: A baseline liver panel is reasonable for anything taken daily and long-term. Beyond that there is nothing specific to chase.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Phenibut — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for Phenibut — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Phenibut
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Comprehensive Metabolic Panel (CMP) | Liver and kidney. Physical dependence and severe withdrawal are the real risks |
| TSH (Thyroid-Stimulating Hormone) | Rule out thyroid before treating anxiety with anything |
| Ferritin | Low iron drives anxiety and is far commoner than people think |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 102 markers A–Z
Phenibut — frequently asked questions
What is Phenibut?
Phenibut (β-phenyl-GABA) is a cognitive & mood research compound. GABA-B (and mild GABA-A) agonist with calcium-channel effects — crosses the blood-brain barrier where GABA can't, producing anxiolysis and sociability.
Is the full Phenibut protocol on this page?
The reported research dose is on this page, along with how Phenibut works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Phenibut?
Phenibut has an approximate half-life of ~5 hrs, which is part of what determines how often it's dosed.
What's the evidence behind Phenibut?
Current evidence level: Human (Russia). Phenibut is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Phenibut protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Phenibut is used for
Phenibut appears under 2 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.